After the identification of cellular myristoylproteins, several groups demonstrated the existence of myristoylated retroviral proteins, and showed an association with transformation. However, many non-transforming viruses also produce myristoylated proteins, and a wide range of functions have been suggested (see Table 1 ). With protein palmitoylation, a clear and defined hypothesis regarding the function of the acylation event was proposed Abbreviations used: HIV-1, human immunodeficiency virus type 1; VSV, herpesvirus varicella-zoster. *To whom correspondence should be addressed. ?Current address: Bureaux of Hygiene and Tropical Diseases, CAB1 International, Wallingford, Oxon. OX10 8DE, U.K.
initially [l] , but more recent data have made the situation progressively more complex. With protein myristoylation we have never had the luxury of a clear hypothesis, but have nevertheless accumulated a similar body of confusing (and sometimes contradictory) data regarding what the fatty acylation actually does.
Myristoylproteins are observed in both membrane-associated and cytoplasmic locations. With retroviruses, myristoylation of transformation-associated proteins is frequently observed, and direct association of myristoylation with transforming or oncogenic activity has also been demonstrated. A recurrent theme is that myristoylation is required to facilitate intracellular localization of the modified proteins, possibly involving transient membrane associations, and this has been shown for a range of 
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Biochemical Society Transactions Table 1 ). Many groups have shown that myristoylation appears to be involved in targeting the transport of proteins during virus assembly, and it appears likely that this is a major role for viral myristoylproteins. In addition several groups have shown the involvement of myristic acid in structural interactions between proteins, most notably in the case of poliovirus, where crystallographic analysis has shown a direct interaction between myristic acid on the amino-terminus of VP4 with a leucine side chain on the VP3 protein [Z] . It now appears from this and other data that a major function of myristoylation may be in mediating and stabilizing protein-protein interactions, which is again highly relevant to virus assembly. Another possibility is reflected in the nature and the location of many myristoylated proteins, suggesting a possible role for viral protein myristoylation in signal transduction, which could affect almost any cellular process.
One recurrent idea, bringing together the proposed roles of myristoylation in intracellular transport and in virus assembly, is that myristoylation is required to position a protein correctly, whether it be for assembly or for some other functional or processing event. A well-defined example of this is the myristoylated pp60"'" protein of Rous sarcoma virus, for which a specific myristoylation-dependent plasma membrane receptor protein has been described [3] . We now know of many viral myristoylated proteins, with a wide range of possible roles. Although some mechanisms appear to be common to different viral myristoylproteins, there is no sign of a single unifying hypothesis of myristoylprotein function, and it appears that such a hypothesis is unlikely to appear.
The next question to ask is: "What use can be made of viral protein myristoylation?" This question has two main answers. In the first place, when studying the role of protein myristoylation in general, viral systems provide accessible and relatively simple models that are readily amenable to biochemical or mutagenic disruption. Such disruption has already produced much information, and will continue to do so. Biochemical disruption by means of highly toxic and non-specific inhibitors such as cerulenin is of very limited use. However, more recent work has identified a range of less toxic compounds with the potential to disrupt normal myristoylation in a relatively specific way. These compounds can block the action of the Nmyristoyltransferase enzyme [4, 5] , or can be attached to proteins in place of myristic acid [6] . In the latter case, substitutions of sulphur or oxygen for methylene groups decrease the hydrophobic nature of the fatty acyl group and alter the properties of the protein [4, 7] . Such work serves to clarify the biochemistry of the events involved, but also has clear potential for antiviral intervention, which represents the second major use for information regarding viral protein myristoylation. Reflecting the wide interest in preventing AIDS, most publications have concentrated on the effect of such compounds in inhibiting the replication of retroviruses, most notably of human immunodeficiency virus type 1 (HIV-1) [4-lo] . However, in our own work we have found that although many such compounds show some level of toxicity, others are both non-toxic and highly effective at inhibiting the replication of a wide range of viruses. Most notably, 2-hydroxytetradecanoic acid (2-hydroxymyristic acid) is non-toxic in cellular systems, but inhibits the replication of the retrovirus HIV-1, the herpesvirus varicella-zoster (VZV), and the picornavirus polio [ 11-1 31. This compound inhibits myristoylation rather than being an alternative substrate [ 141.
The 50% inhibitory concentration for all of these viruses is well below the level at which cellular myristoylation would be blocked, suggesting that even a partial inhibition of myristoylation can disrupt viral replication. In VZV, viral assembly is completely blocked when cellular myristoylation is reduced by one third [15] . It has been suggested that even a complete blocking of cellular myristoylation would not be toxic to cells owing to the stability of cellular myristoylproteins [ 161, but it now appears clear that even a partial disruption of myristoylation may be sufficient to inhibit viral replication.
As both biochemical tools and potential antiviral drugs, myristoylation inhibitors have great potential. Viral systems themselves provide both an opportunity for study and a way to evaluate possible therapies. Such systems appear likely to remain at the forefront of lipoprotein research, which is itself a rapidly expanding area. The future looks interesting.
Introduction
The nefgene of the primate lentiviruses encodes a myristoylated polypeptide of 206 (human immunodeficiency virus type 1 (HIV-1)) to 265 (Simian immunodeficiency virus) amino acids with an apparent molecular mass of between 27 and 35 kDa [ 11. Early studies defined nefas a negative regulator of viral replication; however, there is now a growing consensus that Nef can be considered an essential regulatory protein critical for achieving high viral load and disease progression. A number of functions in vitro have been ascribed to Nef but it is unclear at present how each of these functions conAbbreviations used: GST, glutathione-S-transferase; HIV-1, human immunodeficiency virus type 1; HRP, horseradish peroxidase; myrGST, myristoylated GST; Nef-GST, fusion protein of Nef with GST; Nef(m-)GST, non-myristoylated derivative of Nef-GST; PXXP, proline-rich motif in Nef. tributes to the requirement for Nef in vivo. What is clear is that myristoylation plays an important role in most of these functions and it also follows that Nef myristoylation is critical for the life cycle of the virus in vivo. This conclusion is borne out by the conservation of the myristoylation signal in both laboratory and primary isolates of Nef, despite the high level of variability in the rest of the gene.
Myristoylation has a profound effect on the subcellular localization of Nef transient transfection studies in Cos cells demonstrated that the association of Nef with cytoplasmic membrane structures required myristoylation; however, myristoylated Nef was also found in the cytosol [2, 3] . Non-myristoylated Nef was found in the cytosolic fraction and also in the nucleus. Furthermore myristoylation was shown either to enhance [4], or to be absolutely required for [3] , the binding of Nef to cytoskeletal elements. Interestingly, cytoskeleton binding also required a proline-rich motif implicated in binding
